11 February 2021 : Clinical Research
Effect of ¹³¹I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer
Zhongying Rui1CDEF, Ruixin Wu1BCD, Wei Zheng1ADG*, Xuan Wang1BDF, Zhaowei Meng1AF, Jian Tan1AFDOI: 10.12659/MSM.929590
Med Sci Monit 2021; 27:e929590
Figure 2 Changes in monocyte counts after 131I treatment cycles. The number of monocytes decreased after the first treatment and then gradually increased after the last 3 treatments. While the differences between post-treatment and baseline values were not significant, the last 2 post-treatment values were higher than the value after the first treatment (0.30±0.10 and 0.31±0.09 vs 0.22±0.05, both P=0.001).